Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2024-04-10 4:50 pm Purchase | 2024-03-24 | 13D | Landos Biopharma, Inc. LABP | PERCEPTIVE ADVISORS LLC | 1,486,991 47.700% | 1,486,991![]() (New Position) | Filing History |
2024-04-10 4:50 pm Purchase | 2024-03-24 | 13D | Landos Biopharma, Inc. LABP | Xontogeny LLC | 309,092 9.900% | 309,092![]() (New Position) | Filing History |
2024-02-14 4:01 pm Sale | 2023-12-31 | 13G | Landos Biopharma, Inc. LABP | Bassaganya-Riera Josep | 0 0.000% | -572,087![]() (Position Closed) | Filing History |
2023-03-30 5:27 pm Unchanged | 2023-03-23 | 13D | Landos Biopharma, Inc. LABP | Xontogeny LLC | 309,092 9.900% | 0 (Unchanged) | Filing History |
2023-03-30 4:44 pm Unchanged | 2023-03-23 | 13D | Landos Biopharma, Inc. LABP | PERCEPTIVE ADVISORS LLC | 1,486,992 47.700% | 0 (Unchanged) | Filing History |
2023-02-14 5:00 pm Sale | 2022-12-31 | 13G | Landos Biopharma, Inc. LABP | Bassaganya-Riera Josep | 572,087 14.200% | -65,000![]() (-10.20%) | Filing History |
2023-01-13 5:07 pm Unchanged | 2023-01-10 | 13D | Landos Biopharma, Inc. LABP | PERCEPTIVE ADVISORS LLC | 1,486,992 36.900% | 0 (Unchanged) | Filing History |
2022-11-03 4:15 pm Sale | 2022-11-01 | 13D | Landos Biopharma, Inc. LABP | RTW INVESTMENTS LLC | 0 0.000% | -315,072![]() (Position Closed) | Filing History |
2022-10-31 5:05 pm Sale | 2022-10-27 | 13D | Landos Biopharma, Inc. LABP | RTW INVESTMENTS LLC | 315,072 7.830% | -50,000![]() (-13.70%) | Filing History |
2022-10-06 4:30 pm Sale | 2022-10-04 | 13D | Landos Biopharma, Inc. LABP | RTW INVESTMENTS LLC | 365,072 9.070% | -62,500![]() (-14.62%) | Filing History |
2022-08-09 09:19 am Purchase | 2022-08-09 | 13D | Landos Biopharma, Inc. LABP | Xontogeny LLC | 309,092 7.700% | 309,092![]() (New Position) | Filing History |
2022-08-09 09:15 am Sale | 2022-08-09 | 13D | Landos Biopharma, Inc. LABP | PERCEPTIVE ADVISORS LLC | 1,486,992 36.900% | -309,092![]() (-17.21%) | Filing History |
2022-02-14 5:00 pm Purchase | 2021-12-31 | 13G | Landos Biopharma, Inc. LABP | Bassaganya-Riera Josep | 637,087 15.800% | 637,087![]() (New Position) | Filing History |
2022-02-03 4:49 pm Purchase | 2021-12-31 | 13G | Landos Biopharma, Inc. LABP | Osage University GP III LLC | 182,748 4.500% | 182,748![]() (New Position) | Filing History |
2021-04-06 5:00 pm Unchanged | 2021-03-31 | 13D | Landos Biopharma, Inc. LABP | PERCEPTIVE ADVISORS LLC | 1,796,084 44.800% | 0 (Unchanged) | Filing History |
2021-02-18 5:15 pm Purchase | 2021-02-08 | 13D | Landos Biopharma, Inc. LABP | PERCEPTIVE ADVISORS LLC | 1,796,084 45.900% | 1,796,084![]() (New Position) | Filing History |
2021-02-16 5:23 pm Purchase | 2021-02-04 | 13D | Landos Biopharma, Inc. LABP | RTW INVESTMENTS LLC | 427,572 10.660% | 427,572![]() (New Position) | Filing History |